Global Injectable Anthelmintic Drugs Supply, Demand and Key Producers, 2023-2029

Page: 102

Published Date: 24 Jan 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Injectable Anthelmintic Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Injectable Anthelmintic Drugs demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Injectable Anthelmintic Drugs, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Injectable Anthelmintic Drugs that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Injectable Anthelmintic Drugs total market, 2018-2029, (USD Million)
Global Injectable Anthelmintic Drugs total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Injectable Anthelmintic Drugs total market, key domestic companies and share, (USD Million)
Global Injectable Anthelmintic Drugs revenue by player and market share 2018-2023, (USD Million)
Global Injectable Anthelmintic Drugs total market by Type, CAGR, 2018-2029, (USD Million)
Global Injectable Anthelmintic Drugs total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Injectable Anthelmintic Drugs market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Cipla, Sun Pharmaceutical Industries, Amneal Pharmaceuticals, Zoetis, GlaxoSmithKline, Bayer, Merck and Boehringer Ingelheim International, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Injectable Anthelmintic Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Injectable Anthelmintic Drugs Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Injectable Anthelmintic Drugs Market, Segmentation by Type
    Benzimidazoles
    Piperazine
    Imidazothiazole
    Spiroindoles
    Others

Global Injectable Anthelmintic Drugs Market, Segmentation by Application
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies
    Veterinary Pharmacies
    Others

Companies Profiled:
    Novartis
    Cipla
    Sun Pharmaceutical Industries
    Amneal Pharmaceuticals
    Zoetis
    GlaxoSmithKline
    Bayer
    Merck
    Boehringer Ingelheim International

Key Questions Answered
1. How big is the global Injectable Anthelmintic Drugs market?
2. What is the demand of the global Injectable Anthelmintic Drugs market?
3. What is the year over year growth of the global Injectable Anthelmintic Drugs market?
4. What is the total value of the global Injectable Anthelmintic Drugs market?
5. Who are the major players in the global Injectable Anthelmintic Drugs market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Injectable Anthelmintic Drugs Introduction
    1.2 World Injectable Anthelmintic Drugs Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Injectable Anthelmintic Drugs Total Market by Region (by Headquarter Location)
        1.3.1 World Injectable Anthelmintic Drugs Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Injectable Anthelmintic Drugs Market Size (2018-2029)
        1.3.3 China Injectable Anthelmintic Drugs Market Size (2018-2029)
        1.3.4 Europe Injectable Anthelmintic Drugs Market Size (2018-2029)
        1.3.5 Japan Injectable Anthelmintic Drugs Market Size (2018-2029)
        1.3.6 South Korea Injectable Anthelmintic Drugs Market Size (2018-2029)
        1.3.7 ASEAN Injectable Anthelmintic Drugs Market Size (2018-2029)
        1.3.8 India Injectable Anthelmintic Drugs Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Injectable Anthelmintic Drugs Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Injectable Anthelmintic Drugs Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Injectable Anthelmintic Drugs Consumption Value (2018-2029)
    2.2 World Injectable Anthelmintic Drugs Consumption Value by Region
        2.2.1 World Injectable Anthelmintic Drugs Consumption Value by Region (2018-2023)
        2.2.2 World Injectable Anthelmintic Drugs Consumption Value Forecast by Region (2024-2029)
    2.3 United States Injectable Anthelmintic Drugs Consumption Value (2018-2029)
    2.4 China Injectable Anthelmintic Drugs Consumption Value (2018-2029)
    2.5 Europe Injectable Anthelmintic Drugs Consumption Value (2018-2029)
    2.6 Japan Injectable Anthelmintic Drugs Consumption Value (2018-2029)
    2.7 South Korea Injectable Anthelmintic Drugs Consumption Value (2018-2029)
    2.8 ASEAN Injectable Anthelmintic Drugs Consumption Value (2018-2029)
    2.9 India Injectable Anthelmintic Drugs Consumption Value (2018-2029)

3 World Injectable Anthelmintic Drugs Companies Competitive Analysis
    3.1 World Injectable Anthelmintic Drugs Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Injectable Anthelmintic Drugs Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Injectable Anthelmintic Drugs in 2022
        3.2.3 Global Concentration Ratios (CR8) for Injectable Anthelmintic Drugs in 2022
    3.3 Injectable Anthelmintic Drugs Company Evaluation Quadrant
    3.4 Injectable Anthelmintic Drugs Market: Overall Company Footprint Analysis
        3.4.1 Injectable Anthelmintic Drugs Market: Region Footprint
        3.4.2 Injectable Anthelmintic Drugs Market: Company Product Type Footprint
        3.4.3 Injectable Anthelmintic Drugs Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Injectable Anthelmintic Drugs Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Injectable Anthelmintic Drugs Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Injectable Anthelmintic Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Injectable Anthelmintic Drugs Consumption Value Comparison
        4.2.1 United States VS China: Injectable Anthelmintic Drugs Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Injectable Anthelmintic Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Injectable Anthelmintic Drugs Companies and Market Share, 2018-2023
        4.3.1 United States Based Injectable Anthelmintic Drugs Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Injectable Anthelmintic Drugs Revenue, (2018-2023)
    4.4 China Based Companies Injectable Anthelmintic Drugs Revenue and Market Share, 2018-2023
        4.4.1 China Based Injectable Anthelmintic Drugs Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Injectable Anthelmintic Drugs Revenue, (2018-2023)
    4.5 Rest of World Based Injectable Anthelmintic Drugs Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Injectable Anthelmintic Drugs Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Injectable Anthelmintic Drugs Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Injectable Anthelmintic Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Benzimidazoles
        5.2.2 Piperazine
        5.2.3 Imidazothiazole
        5.2.4 Spiroindoles
        5.2.5 Others
    5.3 Market Segment by Type
        5.3.1 World Injectable Anthelmintic Drugs Market Size by Type (2018-2023)
        5.3.2 World Injectable Anthelmintic Drugs Market Size by Type (2024-2029)
        5.3.3 World Injectable Anthelmintic Drugs Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Injectable Anthelmintic Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospital Pharmacies
        6.2.2 Retail Pharmacies
        6.2.3 Online Pharmacies
        6.2.4 Veterinary Pharmacies
        6.2.5 Veterinary Pharmacies
    6.3 Market Segment by Application
        6.3.1 World Injectable Anthelmintic Drugs Market Size by Application (2018-2023)
        6.3.2 World Injectable Anthelmintic Drugs Market Size by Application (2024-2029)
        6.3.3 World Injectable Anthelmintic Drugs Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Novartis
        7.1.1 Novartis Details
        7.1.2 Novartis Major Business
        7.1.3 Novartis Injectable Anthelmintic Drugs Product and Services
        7.1.4 Novartis Injectable Anthelmintic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Novartis Recent Developments/Updates
        7.1.6 Novartis Competitive Strengths & Weaknesses
    7.2 Cipla
        7.2.1 Cipla Details
        7.2.2 Cipla Major Business
        7.2.3 Cipla Injectable Anthelmintic Drugs Product and Services
        7.2.4 Cipla Injectable Anthelmintic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Cipla Recent Developments/Updates
        7.2.6 Cipla Competitive Strengths & Weaknesses
    7.3 Sun Pharmaceutical Industries
        7.3.1 Sun Pharmaceutical Industries Details
        7.3.2 Sun Pharmaceutical Industries Major Business
        7.3.3 Sun Pharmaceutical Industries Injectable Anthelmintic Drugs Product and Services
        7.3.4 Sun Pharmaceutical Industries Injectable Anthelmintic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Sun Pharmaceutical Industries Recent Developments/Updates
        7.3.6 Sun Pharmaceutical Industries Competitive Strengths & Weaknesses
    7.4 Amneal Pharmaceuticals
        7.4.1 Amneal Pharmaceuticals Details
        7.4.2 Amneal Pharmaceuticals Major Business
        7.4.3 Amneal Pharmaceuticals Injectable Anthelmintic Drugs Product and Services
        7.4.4 Amneal Pharmaceuticals Injectable Anthelmintic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Amneal Pharmaceuticals Recent Developments/Updates
        7.4.6 Amneal Pharmaceuticals Competitive Strengths & Weaknesses
    7.5 Zoetis
        7.5.1 Zoetis Details
        7.5.2 Zoetis Major Business
        7.5.3 Zoetis Injectable Anthelmintic Drugs Product and Services
        7.5.4 Zoetis Injectable Anthelmintic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Zoetis Recent Developments/Updates
        7.5.6 Zoetis Competitive Strengths & Weaknesses
    7.6 GlaxoSmithKline
        7.6.1 GlaxoSmithKline Details
        7.6.2 GlaxoSmithKline Major Business
        7.6.3 GlaxoSmithKline Injectable Anthelmintic Drugs Product and Services
        7.6.4 GlaxoSmithKline Injectable Anthelmintic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 GlaxoSmithKline Recent Developments/Updates
        7.6.6 GlaxoSmithKline Competitive Strengths & Weaknesses
    7.7 Bayer
        7.7.1 Bayer Details
        7.7.2 Bayer Major Business
        7.7.3 Bayer Injectable Anthelmintic Drugs Product and Services
        7.7.4 Bayer Injectable Anthelmintic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Bayer Recent Developments/Updates
        7.7.6 Bayer Competitive Strengths & Weaknesses
    7.8 Merck
        7.8.1 Merck Details
        7.8.2 Merck Major Business
        7.8.3 Merck Injectable Anthelmintic Drugs Product and Services
        7.8.4 Merck Injectable Anthelmintic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Merck Recent Developments/Updates
        7.8.6 Merck Competitive Strengths & Weaknesses
    7.9 Boehringer Ingelheim International
        7.9.1 Boehringer Ingelheim International Details
        7.9.2 Boehringer Ingelheim International Major Business
        7.9.3 Boehringer Ingelheim International Injectable Anthelmintic Drugs Product and Services
        7.9.4 Boehringer Ingelheim International Injectable Anthelmintic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Boehringer Ingelheim International Recent Developments/Updates
        7.9.6 Boehringer Ingelheim International Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Injectable Anthelmintic Drugs Industry Chain
    8.2 Injectable Anthelmintic Drugs Upstream Analysis
    8.3 Injectable Anthelmintic Drugs Midstream Analysis
    8.4 Injectable Anthelmintic Drugs Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Injectable Anthelmintic Drugs Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Injectable Anthelmintic Drugs Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Injectable Anthelmintic Drugs Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Injectable Anthelmintic Drugs Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Injectable Anthelmintic Drugs Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Injectable Anthelmintic Drugs Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Injectable Anthelmintic Drugs Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Injectable Anthelmintic Drugs Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Injectable Anthelmintic Drugs Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Injectable Anthelmintic Drugs Players in 2022
    Table 12. World Injectable Anthelmintic Drugs Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Injectable Anthelmintic Drugs Company Evaluation Quadrant
    Table 14. Head Office of Key Injectable Anthelmintic Drugs Player
    Table 15. Injectable Anthelmintic Drugs Market: Company Product Type Footprint
    Table 16. Injectable Anthelmintic Drugs Market: Company Product Application Footprint
    Table 17. Injectable Anthelmintic Drugs Mergers & Acquisitions Activity
    Table 18. United States VS China Injectable Anthelmintic Drugs Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Injectable Anthelmintic Drugs Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Injectable Anthelmintic Drugs Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Injectable Anthelmintic Drugs Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Injectable Anthelmintic Drugs Revenue Market Share (2018-2023)
    Table 23. China Based Injectable Anthelmintic Drugs Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Injectable Anthelmintic Drugs Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Injectable Anthelmintic Drugs Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Injectable Anthelmintic Drugs Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Injectable Anthelmintic Drugs Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Injectable Anthelmintic Drugs Revenue Market Share (2018-2023)
    Table 29. World Injectable Anthelmintic Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Injectable Anthelmintic Drugs Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Injectable Anthelmintic Drugs Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Injectable Anthelmintic Drugs Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Injectable Anthelmintic Drugs Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Injectable Anthelmintic Drugs Market Size by Application (2024-2029) & (USD Million)
    Table 35. Novartis Basic Information, Area Served and Competitors
    Table 36. Novartis Major Business
    Table 37. Novartis Injectable Anthelmintic Drugs Product and Services
    Table 38. Novartis Injectable Anthelmintic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Novartis Recent Developments/Updates
    Table 40. Novartis Competitive Strengths & Weaknesses
    Table 41. Cipla Basic Information, Area Served and Competitors
    Table 42. Cipla Major Business
    Table 43. Cipla Injectable Anthelmintic Drugs Product and Services
    Table 44. Cipla Injectable Anthelmintic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Cipla Recent Developments/Updates
    Table 46. Cipla Competitive Strengths & Weaknesses
    Table 47. Sun Pharmaceutical Industries Basic Information, Area Served and Competitors
    Table 48. Sun Pharmaceutical Industries Major Business
    Table 49. Sun Pharmaceutical Industries Injectable Anthelmintic Drugs Product and Services
    Table 50. Sun Pharmaceutical Industries Injectable Anthelmintic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Sun Pharmaceutical Industries Recent Developments/Updates
    Table 52. Sun Pharmaceutical Industries Competitive Strengths & Weaknesses
    Table 53. Amneal Pharmaceuticals Basic Information, Area Served and Competitors
    Table 54. Amneal Pharmaceuticals Major Business
    Table 55. Amneal Pharmaceuticals Injectable Anthelmintic Drugs Product and Services
    Table 56. Amneal Pharmaceuticals Injectable Anthelmintic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Amneal Pharmaceuticals Recent Developments/Updates
    Table 58. Amneal Pharmaceuticals Competitive Strengths & Weaknesses
    Table 59. Zoetis Basic Information, Area Served and Competitors
    Table 60. Zoetis Major Business
    Table 61. Zoetis Injectable Anthelmintic Drugs Product and Services
    Table 62. Zoetis Injectable Anthelmintic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Zoetis Recent Developments/Updates
    Table 64. Zoetis Competitive Strengths & Weaknesses
    Table 65. GlaxoSmithKline Basic Information, Area Served and Competitors
    Table 66. GlaxoSmithKline Major Business
    Table 67. GlaxoSmithKline Injectable Anthelmintic Drugs Product and Services
    Table 68. GlaxoSmithKline Injectable Anthelmintic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. GlaxoSmithKline Recent Developments/Updates
    Table 70. GlaxoSmithKline Competitive Strengths & Weaknesses
    Table 71. Bayer Basic Information, Area Served and Competitors
    Table 72. Bayer Major Business
    Table 73. Bayer Injectable Anthelmintic Drugs Product and Services
    Table 74. Bayer Injectable Anthelmintic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Bayer Recent Developments/Updates
    Table 76. Bayer Competitive Strengths & Weaknesses
    Table 77. Merck Basic Information, Area Served and Competitors
    Table 78. Merck Major Business
    Table 79. Merck Injectable Anthelmintic Drugs Product and Services
    Table 80. Merck Injectable Anthelmintic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Merck Recent Developments/Updates
    Table 82. Boehringer Ingelheim International Basic Information, Area Served and Competitors
    Table 83. Boehringer Ingelheim International Major Business
    Table 84. Boehringer Ingelheim International Injectable Anthelmintic Drugs Product and Services
    Table 85. Boehringer Ingelheim International Injectable Anthelmintic Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 86. Global Key Players of Injectable Anthelmintic Drugs Upstream (Raw Materials)
    Table 87. Injectable Anthelmintic Drugs Typical Customers
List of Figure
    Figure 1. Injectable Anthelmintic Drugs Picture
    Figure 2. World Injectable Anthelmintic Drugs Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Injectable Anthelmintic Drugs Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Injectable Anthelmintic Drugs Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Injectable Anthelmintic Drugs Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Injectable Anthelmintic Drugs Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Injectable Anthelmintic Drugs Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Injectable Anthelmintic Drugs Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Injectable Anthelmintic Drugs Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Injectable Anthelmintic Drugs Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Injectable Anthelmintic Drugs Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Injectable Anthelmintic Drugs Revenue (2018-2029) & (USD Million)
    Figure 13. Injectable Anthelmintic Drugs Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Injectable Anthelmintic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Injectable Anthelmintic Drugs Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Injectable Anthelmintic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Injectable Anthelmintic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Injectable Anthelmintic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Injectable Anthelmintic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Injectable Anthelmintic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Injectable Anthelmintic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Injectable Anthelmintic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Injectable Anthelmintic Drugs by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Injectable Anthelmintic Drugs Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Injectable Anthelmintic Drugs Markets in 2022
    Figure 27. United States VS China: Injectable Anthelmintic Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Injectable Anthelmintic Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Injectable Anthelmintic Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Injectable Anthelmintic Drugs Market Size Market Share by Type in 2022
    Figure 31. Benzimidazoles
    Figure 32. Piperazine
    Figure 33. Imidazothiazole
    Figure 34. Spiroindoles
    Figure 35. Others
    Figure 36. World Injectable Anthelmintic Drugs Market Size Market Share by Type (2018-2029)
    Figure 37. World Injectable Anthelmintic Drugs Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 38. World Injectable Anthelmintic Drugs Market Size Market Share by Application in 2022
    Figure 39. Hospital Pharmacies
    Figure 40. Retail Pharmacies
    Figure 41. Online Pharmacies
    Figure 42. Veterinary Pharmacies
    Figure 43. Others
    Figure 44. Injectable Anthelmintic Drugs Industrial Chain
    Figure 45. Methodology
    Figure 46. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Novartis
Cipla
Sun Pharmaceutical Industries
Amneal Pharmaceuticals
Zoetis
GlaxoSmithKline
Bayer
Merck
Boehringer Ingelheim International

Related Reports

Global Injectable Anthelmintic Drugs Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Injectable Anthelmintic Drugs Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 11 Jan 2023

date Medical Care

According to our (Global Info Research) latest study, the global Injectable Anthelmintic Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Injectable Anthelmintic Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Injectable Anthelmintic Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 07 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Injectable Anthelmintic Drugs market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Global Injectable Anthelmintic Drugs Supply, Demand and Key Producers, 2024-2030

Global Injectable Anthelmintic Drugs Supply, Demand and Key Producers, 2024-2030

date 29 Feb 2024

date Medical Care

The global Injectable Anthelmintic Drugs market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

Injectable Anthelmintic Drugs

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>